Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 497,300 | 508,200 | 515,000 | 484,800 | 506,800 |
| Cost of Goods | 326,800 | 342,700 | 371,000 | 385,700 | 342,000 |
| Gross Profit | 170,500 | 165,500 | 144,000 | 99,100 | 164,800 |
| Operating Expenses | 87,100 | 80,700 | 83,300 | 119,900 | 81,900 |
| Operating Income | 84,200 | 85,500 | 60,700 | -20,100 | 82,900 |
| Interest Expense | 4,000 | 3,900 | 3,700 | 5,100 | 3,100 |
| Other Income | -1,500 | -1,800 | 300 | -26,900 | -1,600 |
| Pre-tax Income | 78,700 | 79,800 | 57,300 | -52,100 | 78,200 |
| Income Tax | 19,200 | 23,600 | 14,800 | -24,000 | 24,400 |
| Net Income Continuous | 59,500 | 56,200 | 42,500 | -28,100 | 53,800 |
| Net Income Discontinuous | N/A | -1,500 | N/A | -1,200 | -200 |
| Net Income | $59,500 | $54,700 | $42,500 | $-29,300 | $53,600 |
| EPS Basic Total Ops | 0.83 | 0.76 | 0.59 | -0.41 | 0.74 |
| EPS Basic Continuous Ops | 0.83 | 0.78 | 0.59 | -0.38 | 0.74 |
| EPS Basic Discontinuous Ops | N/A | -0.02 | N/A | -0.03 | 0.00 |
| EPS Diluted Total Ops | 0.81 | 0.75 | 0.58 | -0.40 | 0.73 |
| EPS Diluted Continuous Ops | 0.81 | 0.77 | 0.58 | -0.38 | 0.73 |
| EPS Diluted Discontinuous Ops | N/A | -0.02 | N/A | -0.02 | 0.00 |
| EBITDA(a) | $105,700 | $108,100 | $82,100 | $1,500 | $103,400 |